2m 2m 2m 2m 2m 2m 2m
Myriad Genetics (MYGN)
NASDAQ
$5.68+$0.10 (+1.89%)
Price as of Oct 22, 2026 7:55 PM EDT- $532.8MMarket Cap
- -29.13%1-Year Change
- Diagnostics & ResearchIndustry
Myriad Genetics (MYGN)
$5.68+$0.10 (+1.89%)
MYGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.57 | ||
Change | +$0.03 (+0.54%) | ||
Open | $5.60 | ||
High | $5.74 | ||
Low | $5.45 | ||
Previous Close | $5.54 | ||
Volume | 4,951,629 | ||
30-Day Average Volume | 2,830,027 | ||
1-Week Change | 34.22% | ||
1-Month Change | 38.90% | ||
1-Year Change | -29.13% | ||
3-Year Change | -63.04% | ||
5-Year Change | -82.86% | ||
Fundamentals | |||
Shares Outstanding | 95.6M | ||
Total Assets | $638.9M | ||
Market Cap | $532.8M | ||
Enterprise Value | $538.3M | ||
Period: QTR TTM FY | |||
Revenue | $190.7M | ||
Net Income | -$43.2M | ||
Free Cash Flow | -$8.3M | ||
EBIT | -$42.6M | ||
EBITDA | -$30.1M | ||
Net Working Capital | $158.3M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -64 | ||
Price/Operating Cash Flow | -64 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 03/26/2009 | ||
Earnings & Revenue